A new flash report from the WCRI highlights trends in drug utilization.
A new flash report from the WCRI highlights trends in drug utilization.
A new 8 mg naloxone nasal spray will soon be available, which is the largest naloxone dose approved by the FDA to date.
A new report from IQVIA found that national MME dropped 17% from 2019 to 2020.
Alleged violations of the Controlled Substances Act could result in billions of dollars in penalties.
The drug manufacturer is pleading guilty and paying out billions.
Olinvyk injections and Qdolo oral solution are approved for the management of acute pain.
The FDA recommends healthcare professionals co-prescribe the opioid overdose reversal drug with all opioid prescriptions.
Healthesystems’ VP of Clinical Services addresses COVID-19 disruptions to workers’ comp, along with helpful strategies
AMA hopes to shift from a crisis-reaction framework to a more holistic model that prevents overdose while helping pain patients receive care.
The AMA suggests that prescription medications are no longer a significant factor in the opioid epidemic, and that opioid prescription limits should change.
